AbbVie Inc. (ABBV)
NYSE: ABBV · IEX Real-Time Price · USD
182.10
+1.75 (0.97%)
Mar 28, 2024, 4:00 PM EDT - Market closed
AbbVie Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for AbbVie stock have an average target of 182.18, with a low estimate of 150 and a high estimate of 196. The average target predicts an increase of 0.04% from the current stock price of 182.10.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AbbVie stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Buy | 8 | 8 | 6 | 7 | 8 | 7 |
Hold | 9 | 9 | 8 | 7 | 7 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 20 | 20 | 17 | 17 | 18 | 13 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Barclays | Barclays | Buy Maintains $185 → $195 | Buy | Maintains | $185 → $195 | +7.08% | Mar 27, 2024 |
Guggenheim | Guggenheim | Strong Buy Maintains $188 → $190 | Strong Buy | Maintains | $188 → $190 | +4.34% | Mar 22, 2024 |
Raymond James | Raymond James | Buy Maintains $181 → $189 | Buy | Maintains | $181 → $189 | +3.79% | Feb 6, 2024 |
Truist Securities | Truist Securities | Strong Buy Maintains $180 → $195 | Strong Buy | Maintains | $180 → $195 | +7.08% | Feb 6, 2024 |
Raymond James | Raymond James | Buy Maintains $181 → $189 | Buy | Maintains | $181 → $189 | +3.79% | Feb 5, 2024 |
Financial Forecast
Revenue This Year
55.63B
from 54.32B
Increased by 2.42%
Revenue Next Year
59.05B
from 55.63B
Increased by 6.15%
EPS This Year
11.41
from 2.72
Increased by 319.64%
EPS Next Year
12.45
from 11.41
Increased by 9.09%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 58.2B | 63.8B | 68.8B | 69.5B | 72.7B |
Avg | 55.6B | 59.1B | 63.3B | 62.0B | 64.4B |
Low | 52.8B | 54.6B | 57.1B | 53.1B | 55.7B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 7.1% | 14.8% | 16.6% | 9.8% | 17.3% |
Avg | 2.4% | 6.2% | 7.1% | -2.0% | 3.8% |
Low | -2.8% | -1.8% | -3.3% | -16.0% | -10.2% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 12.14 | 13.70 | 15.16 | 16.61 | 17.65 |
Avg | 11.41 | 12.45 | 13.73 | 14.24 | 15.26 |
Low | 10.63 | 11.27 | 12.40 | 11.06 | 11.20 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 346.3% | 20.1% | 21.8% | 21.0% | 24.0% |
Avg | 319.6% | 9.1% | 10.3% | 3.7% | 7.2% |
Low | 290.9% | -1.3% | -0.4% | -19.4% | -21.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.